Introduction
Larvae of the arctiid moths, Creatonotos transiens and C. gangis are polyphagous. When feeding on plants with pyrrolizidine alkaloids (PA), the insects accumulate and store PAs [1] , and thus appear to gain chemical defence. In male insects, PAs induce the development of abdominal scent organs (coremata) [2] , Furthermore, the heterocyclic moiety of PAs is transformed into a dihydro-5H-pyrrolizine pheromone, hydroxydanaidal (I), which is secreted and dissipated by the coremata [3] .
Hydroxydanaidal (I) possesses an asymmetric carbon atom (C-7), which is also present in its alkaloidal precursor. When PAs of the retronecine (7 R) (II)-type are exploited for pheromone biosynthesis, the configuration at this center does not need to change. But 75-heliotrine (III), which has the "wrong" configuration at C-7, can also serve as a precursor for Abbreviations: GLC, gas-liquid chromatography; MS, mass spectrometry; EI, electron impact; CI, chemical ionization; TMS, trimethylsilyl; MSTFA, N-methyl-N-(trimethylsilyl)trifluoroacetamide; PA, pyrrolizidine alkaloids. R( -)-hydroxydanaidal (I) [3, 4] , It was therefore assumed that 75-heliotrine or a derivative undergoes a net inversion of the C-7 stereochemistry. We now determined the stage of pheromone biosynthesis at which the stereochemical conversion at C-7 presumably takes place.
Materials and Methods
Late instar larvae (L7) of C. transiens received purified 75-heliotrine (commercially available from Corkwood Enterpr., Blakehurst, NSW Australia) as I i n the sole PA-source (5 mg PA/larva) in an artificial diet [5] . Larvae, prepupae, pupae, and imagines were homogenized in 0.5 M HCl. Zinc powder was added to reduce the PA-N-oxides, the dominant alkaloidal form of PAs in C. transiens [6] to free PAs. After 3 h at room temperature the homogenate was made alkaline with 2 M NaOH and applied onto Chemelute columns (ICT, Frankfurt). Alkaloids were eluted with methylene chloride and analyzed by capillary gas-liquid chromatography (Fig. 1) [7] . NMR measurements were made on a Bruker AM 360.
Results and Discussion
Whereas the original 75-heliotrine (III) resulted in a single GLC-peak, we detected two major peaks in alkaloid extracts from larvae and subsequent developmental stages (Fig. 1 A, B) . The abundance of the new compound increased in later stages and reached 43-66% in females and nearly 80% in males as compared to the amount of total pyrrolizidine alkaloids (= 100%) recovered (Table I) . * Mean of 2 animals (4 in case of imagines). ** Larvae obtained 5000 ng 75-heliotrine each with their diet. About 670 ng PA were recovered from the animals (mean value of 32 animals), 742 ng from their faeces (9 animals). Whether the missing amounts were completely metabolized will be determined in further studies.
GLC-MS analysis (EI and CI-MS) of both GLCpeaks gave nearly identical mass spectra (Table II) , indicating that the new compound was a stereoisomer of 75-heliotrine (III). Some minor metabolites could also be detected, one of which was found to be callimorphine (V), which had previously been identified as a PA-derived compound in the arctiids Tyria jacobaea, Arctia caja and Callimorpha dominula [8] ,
In order to see whether the new metabolite was the 7i?(-)-isomer of heliotrine (IV), (i.e. the pheromone precursor with the correct stereochemistry at C-7) heliotrine and its isomer were hydrolyzed in 5% NaOH (1 h at 80 °C), extracted with ethylacetate, derivatized with MSTFA and finally analyzed by GLC and GLC-MS. Two distinct compounds could be separated by capillary GLC (Table II) , i.e. the TMS-derivatives of retronecine (II) and of heliotridine, with identical mass spectra (Table II) . TMSderivatives were also produced from the necine acids, i.e. heliotrinic acid, of the molecules. They resulted in a single GLC-peak (Table II) which means that the stereochemical difference should be restricted to the pyrrolizidine nucleus.
Carbon-13 NMR analysis allowed us to decide whether the hydroxyl-group at C-7 had the R-or 5-configuration: 13 C NMR.analysis of the heliotrine metabolite, isolated from ca. 500 animals fed with 75-heliotrine (III) and of the original 75-heliotrine (III), indeed shows that a net inversion of the C-7 stereochemistry took place ( Fig. 2A, B) : The signal for C-7 is at about 75 ppm for the S-configuration (Fig. 2 A) and at 70 ppm for the Ä-type as determined in [9] , In a control experiment we oxidized 400 mg 75-heliotrine (III) with pyridinium dichromat (PDC) (1 g PDC in 2 ml methylene chloride; 20 h at room temperature) to the corresponding ketone (which was not found as a metabolite in C. transiens). The product was purified on a chemelute column (s. above) and reduced with sodium borohydride in methanol.
l3 C NMR data (Fig. 2C ) of this product clearly show that a racemization took place at C-7 resulting in a mixture of 7R-and 75-heliotrine (III/IV), i.e. corresponding signals are present at 75 and 70 ppm. The origin and meaning of the signal at 74.5 ppm (in Fig.  2B, C) is not clear yet.
The NMR, GLC, and GLC-MS data clearly show that 75-heliotrine is (in an as yet unknown process) metabolized to 7Ä-heliotrine by C. transiens, which then has the correct configuration for the biosynthesis of R(-)-hydroxydanaidal.
The minor metabolite, callimorphine (V) also has the ^-configuration, and is thus probably also derived from 7Ä-heliotrine. In Creatonotos, 7 R-and 7 5-heliotrine are present by up to 90% as their N-oxides (VI) [6] . To our knowledge, both 77?-heliotrine and 7/?-heliotrine-N-oxide have not been described before and are new natural alkaloids.
In order to explain the capacity of Creatonotos to use a variety of PAs with either the common 7 R-and/ or even the less common 75-configuration as precursors for the synthesis of 7/?-hydroxydanaidal (I) [3] , a possible conversion mechanism was postulated [4] . From our data presented in this communication it can be concluded that the conversion takes place at the level of the ester alkaloid and not at the level of hydroxydanaidal.
But the stereochemical conversion at C-7 of the heliotrine nucleus could be an even more general C NMR analysis of 75-heliotrine and its metabolites. A. 75-heliotrine; B. 7ft-heliotrine*, the metabolite from 5. transiens; C. racemization product of 75-heliotrine in CDCI3. * ca. 80% 7/?-heliotrine according to GLC-analysis.
